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PImprovement in Cardiac Function With Small
Intestine Extracellular Matrix Is Associated
With Recruitment of C-Kit Cells, Myofibroblasts,
and Macrophages After Myocardial Infarction
Zhi-Qing Zhao, MD, PHD,* John D. Puskas, MD,† Di Xu, MD,† Ning-Ping Wang, MD,*
Mario Mosunjac, MD,† Robert A. Guyton, MD,† Jakob Vinten-Johansen, PHD,†
Robert Matheny, MD‡
Savannah and Atlanta, Georgia
Objectives This study tested the hypothesis that modulation of angiogenesis and cardiac function by injecting small intes-
tine extracellular matrix emulsion (EMU) into myocardium is associated with recruitment of c-kit cells, myofibro-
blasts, and macrophages after myocardial infarction.
Background Degradation of native extracellular matrix has been associated with adverse cardiac remodeling after infarction.
Methods Sixty-four rats were subjected to 45 min ischemia followed by 3, 7, 21, and 42 days of reperfusion, respectively. Sa-
line or EMU (30 to 50 l) was injected into the area at risk myocardium after reperfusion. Histological examination
was performed by immunohistochemical staining, and cardiac function was analyzed using echocardiography.
Results The population of c-kit–positive cells in infarcted myocardium with the EMU injection increased significantly rela-
tive to the saline control at 7 days of reperfusion. Along with this change, alpha-smooth muscle actin expressing
myofibroblasts and macrophages accumulated to a significant extent compared with the saline control. In-
creased vascular endothelial growth factor protein level and strong immunoreactivity of vascular endothelial
growth factor expression were observed. Angiogenesis in the EMU area was significantly enhanced relative to the
saline control, evidenced by increased density of -smooth muscle actin positive vessels. Furthermore, echocar-
diography showed significant improvements in fractional shortening, ejection fraction, and stroke volume in the
EMU group. The wall thickness of the infarcted middle anterior septum in the EMU group was significantly in-
creased relative to the saline control.
Conclusions We show for the first time that injection of EMU into the infarcted myocardium increases neovascularization and
preserves cardiac function, potentially mediated by enhanced recruitment of c-kit–positive cells, myofibroblasts,
and macrophages. (J Am Coll Cardiol 2010;55:1250–61) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.10.049o
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the maladaptive ventricular remodeling initiated by myo-
ardial infarction is characterized by progressive infarct expan-
ion, wall thinning, and chamber dilation. During the early
tage of myocardial infarction, the extracellular matrix (ECM)
s degraded by matrix metalloproteinases leading to expansion
rom the *Cardiovascular Research Laboratory, Mercer University School of Medi-
ine, Savannah, Georgia; †Cardiothoracic Research Laboratory, Department of
athology, Carlyle Fraser Heart Center/Crawford Long Hospital, Emory University,
tlanta, Georgia; and ‡CorMatrix Cardiovascular, Inc., Atlanta, Georgia. This study
as supported by CorMatrix Cardiovascular, Inc., Atlanta, Georgia. Dr. Matheny is
n employed as Scientific Director of CorMatrix Cardiovascular Inc. This study was
resented at the American College of Cardiology Annual Scientific Sessions,
hicago, Illinois, 2008.t
Manuscript received June 18, 2009; revised manuscript received September 29,
009, accepted October 5, 2009.f the infarcted zone. This is followed by a later phase of
ealing during which myofibroblasts proliferate and deposit
ollagen to form reparative fibrosis and scar tissue (1–4).
Over the years, much attention has been placed on tissue
egenerative therapy with cell transplantation after myocar-
ial infarction in an attempt to improve angiogenesis,
eplenish dead cardiomyocytes, and preserve cardiac func-
ion. However, it has not been consistently reported that
nvariant reconstitution of infarcted myocardium and blood
essels with cell transplantation is well integrated structur-
lly and functionally in the ventricular wall (5–8). Recent
tudies have begun to provide promising alternatives to the
ypical cellular transplantation technique, using biomaterials
o modulate cardiac repair. These biomaterials, including
fi
(
i
T
t
r
b
c
s
e
c
l
a
n
a
I
p
w
r
i
a
m
E
r
a
M
S
h
a
N
r
a
s
T
w
(
a
t
s
c
i
l
w
o
t
t
P
i
p
o
m
a
t
t
l
c
b
m
p
p
t
v
T
u
w
f
E
w
g
(
(
t
1
s
p
m
c
o
r
n
e
a
p
g
t
s
o
p
e
v
C
E
s
M
M
T
a
M
v
(
s
L
d
E
E
i
1251JACC Vol. 55, No. 12, 2010 Zhao et al.
March 23, 2010:1250–61 EMU and Cardiac Remodelingbrin glue (5), collagen (9), self-assembled nanopeptides
10), and alginate (11), can be directly injected into the
nfarcted myocardium to improve healing and remodeling.
he mechanisms most likely involved include increased wall
hickness and improved neovascularization (12).
Constructs of extracellular matrix emulsion (EMU) de-
ived from acellular porcine small intestine submucosa have
een shown to promote angiogenesis and the formation of
ardiac tissue in patch studies of the right ventricle and atrial
eptum (13). The acellular EMU under study, which is an
mulsion of the porcine small intestinal submucosa, primarily
ontains natural sources of glycoproteins (fibronectin and
aminin) and glycosaminoglycans (heparan, hyaluronic
cid, and chondroitin sulfate) in a complex of structures
ecessary for proper cell attachment and function. In
ddition, type I collagen with smaller amounts of type III,
V, V, and VI are also identified in this EMU.
However, we do not know whether this purified EMU
romotes cardiac repair and improves cardiac function, and
hether EMU has the capability to recruit endogenous cells
esponsible for protection when it is injected into the
nfarcted heart. Therefore, we tested the hypothesis that
lleviation of maladaptive cardiac remodeling and improve-
ent of cardiac function with intramyocardial injection of
MU are associated with mobilization of bone marrow
esident progenitor cells (i.e., c-kit–positive cells), prolifer-
tion of myofibroblasts, and infiltration of macrophages.
ethods
urgical preparation of animals. All animals received
umane care in compliance with “The Guide for the Care
nd Use of Laboratory Animals” published by the U.S.
ational Institutes of Health (NIH Publication No. 85-23,
evised 1996).
Male Sprague-Dawley rats weighing 400 to 450 g were
nesthetized with an initial intraperitoneal injection of
odium pentobarbital (40 to 50 mg/kg) to induce anesthesia.
he animals were intubated and mechanically ventilated
ith oxygen-enriched room air using a rodent respirator
Harvard Rodent Ventilator Model 683), the rate was
djusted to 30 to 40 breaths/min, and tidal volume was set
o 1.1 to 1.3 ml/100 g body weight. Procedures on the first
urgical day were performed under sterile conditions. The
hest was opened by a left thoracotomy through the fourth
ntercostal space. After pericardiotomy, a 6-0 polypropyline
igature was placed under the left coronary artery (LCA)
here it emerged from beneath the left atrium, and the ends
f the tie were threaded through a small plastic tube (PE50)
o form a snare for reversible LCA occlusion. The body
emperature was maintained constant at 37°C by a heating pad.
reparation of EMU. The EMU was prepared by harvest-
ng the small intestine submucosa from a porcine source as
reviously described (14). Briefly, the small intestine was
pened longitudinally and rinsed with sterile saline. It was then
echanically stripped from the surrounding smooth muscle mnd serosal layers and from the
unica mucosa, often leaving intact
he basilar layers. The remaining
ayer was predominately submu-
osa with the basement mem-
rane. The remaining cellular ele-
ents were removed with 0.1%
eracetic acid and rinsed in
hosphate-buffered saline and dis-
illed water. The sheets were cut to
arious lengths and freeze dried.
hey were then made into partic-
late by grinding and rehydrated
ith sterile saline to a suspension
or injection.
xperimental protocol. The rats
ere randomly allocated to 1 of 4
roups. 1) Saline control group
n  8 at each time point): saline
30 to 50 l) was injected into
he ischemic myocardium after
5 min of reperfusion. 2) Emul-
ion group (n  8 at each time
oint): EMU (30 to 50 l) was injected into the ischemic
yocardium after 15 min of reperfusion. The rats in the
ontrol and EMU groups were subjected to 45 min LCA
cclusion followed by 3, 7, 21, and 42 days of reperfusion,
espectively. All injections were made through a 30G
eedle, and successful injection was visualized by the pres-
nce of EMU on the site of injection. 3) sham group (n  3
t each time point): the chest was opened and a ligature was
laced under LCA without occlusion. 4) sham plus EMU
roup (n  3 at each time point): EMU was injected into
he normal myocardium. Observational time points in the
ham and sham plus EMU groups were the same as those in
ther experimental groups. After the injection was com-
leted, the incisions were closed in layers. The chest and
ndotracheal tubes were removed when the animal was
entilator independent.
ardiac function and wall thickness by echocardiography.
chocardiography was used to assess left ventricle (LV)
ystolic and diastolic function using a 2-dimensional guided
-mode ultrasound system (Acuson Sequoia, Siemens
edical Solutions, Mountain View, California) (15,16).
wo-dimensional images from a short-axis view of the LV
t the level of the papillary muscles were obtained using a 15
Hz linear transducer at a paper speed of 100 mm/s. Left
entricular percent fraction shortening and ejection fraction
EF) were calculated using the following equations: fraction
hortening (%) was calculated as: [(LVDD  LVSD)/
VDD]  100, where LVDD is left ventricular diastolic
imension, and LVSD is left ventricular systolic dimension.
jection fraction (%) was calculated as: [(EDV  ESV)/
DV] 100, where EDV is end-diastolic volume and ESV
s end-systolic volume. Pulsed-wave Doppler spectra of
Abbreviations
and Acronyms
ECM  extracellular matrix
EDV  end-diastolic volume
EF  ejection fraction
EMU  extracellular matrix
emulsion
ESV  end-systolic volume
IgG  immunoglobulin G
LCA  left coronary artery
LV  left ventricle
LVDD  left ventricular
diastolic dimension
LVSD  left ventricular
systolic dimension
SCF  stem cell factor
SMA  smooth muscle
actin
VEGF  vascular
endothelial growth factoritral inflow from the apical 4-chamber view was used to
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EMU and Cardiac Remodeling March 23, 2010:1250–61ssess LV diastolic flow characteristics by calculating a ratio
f early diastolic filling (E-wave) velocity and atrial filling
A-wave) velocity. The interventricular septum and poste-
ior wall thickness were measured on the 2-dimensional images
t the level of the papillary muscles, which was frozen at the
nd of diastole. The echocardiography was performed before
pening the chest (baseline) and during the time course of the
xperiment in all groups. All measurements were averaged over
consecutive cardiac cycles.
istological preparation. At the end of each experiment,
he LCA was re-ligated and 1 ml of 20% Unisperse blue dye
Ciba-Geigy, Dover Township, New Jersey) was directly
njected into the LV to outline the nonischemic and area at
isk myocardium. The animal was euthanized, and the heart
as removed. The transverse slices including the nonisch-
mic and ischemic zones were fixed in 10% phosphate-
uffered formalin solution for 24 h, and embedded in
araffin for histological analysis. Cryosections (5-m thick)
ere obtained using a Microtome (Leica RM2135, Hous-
on, Texas). For Western blot analysis, the nonischemic and
schemic zones were immediately frozen in liquid nitrogen
nd kept at 70°C until use.
ollagen deposition by Masson’s trichrome staining.
asson’s trichrome is a 3-color staining protocol that stains
ollagen blue, nuclei black, and muscle fiber red. It has been
reviously validated through immunohistochemistry as an
ccurate technique for evaluating collagen deposition within
uscle (Ancillary Pathways, Miami, Florida). Briefly, the
issue blocks were fixed in 10% buffered formalin and
rocessed for paraffin embedding. Paraffin sections (5 m)
ere hydrated with distilled water and stained with Mas-
on’s trichrome, which determines the relative proportion of
ollagen deposition in the infarcted myocardium.
mmunohistochemistry. Immunohistochemical staining
n tissue sections was performed as described previously
17). In brief, paraffin-embedded blocks were deparaffinized
n xylene and dehydrated in graded ethanol. The prepared
ransverse paraffin sections were stained using the following
ntibodies: a polyclonal antibody against c-kit (C-19, Santa
ruz Biotechnology, Santa Cruz, California); a monoclonal
nti–-smooth muscle actin (SMA) (Clone 1A4, Sigma, St.
ouis, Missouri); a polyclonal antibody against vascular
ndothelial growth factor (VEGF [147, Santa Cruz Bio-
echnology]), and a monoclonal antibody against macro-
hages (CD68, Millipore, Temecula, California). The slides
ere washed in phosphate-buffered saline, incubated with a
iotinylated horse anti-rabbit immunoglobulin G (IgG) or
nti-mouse IgG (Vector Laboratories, Burlingame, Califor-
ia), stained using the ABC-peroxidase kit or ABC-AR
alkaline phosphatase, Vector Laboratories), and then sub-
trated with 3,3’-diaminobenzidine tetrahydrochloride or
lkaline phosphatase substrate kit (Sigma). Quality of im-
unohistochemistry assay was controlled by either elimina-
ion of the primary antibody or incubation of the tissue with
nonimmune IgG. Data were analyzed in a blinded manner
sing computed-assisted morphometry (Image-Pro Plus E.5, Media Cybernetics, Silver Spring, Maryland). Accumu-
ation of -SMA–expressing myofibroblasts and macro-
hages were calculated as mean number from 8 randomized
igh-powered fields on each slide. The density of arterioles
efined was assessed from the average number of vessels that
ere positive for -SMA. Expression of VEGF was simi-
arly counted as mean density from 8 randomized high-
owered fields on each slide and. Eight tissue blocks from
ach group were analyzed. All slides were evaluated at 200
imes magnification.
estern blotting analysis. Western blotting was per-
ormed as described previously (17). In brief, freshly frozen
onischemic and ischemic tissue samples were homogenized in
ysis buffer and protein concentration was measured by the DC
rotein Assay (Bio-Rad, Hercules, California). The protein
as then boiled and loaded onto gradient sodium dodecyl
ulfate–polyacrylamide gel using Mini Protean II Dual Stab
ell (Bio-Rad). Membranes were subsequently exposed to a
abbit polyclonal antibody against stem cell factor (SCF [Santa
ruz Biotechnology]) and polyclonal antibody against VEGF
Santa Cruz Biotechnology). Bound antibody was detected by
orseradish peroxidase conjugated anti-rabbit IgG. The mem-
rane was incubated with chemiluminescence substrate and
xposed to an x-ray film. The SCF was detected at bands of
5-/31-kDa and VEGF at 21-kDa. The scanned images were
mported into Adobe Photoshop, and the intensity of bands
rom the nonischemic and ischemic tissues was shown as
rbitrary units.
tatistical analysis. Data were reported as the mean  SE.
1-way analysis of variance (SigmaStat, version 3.5, SPSS,
nc., Chicago, Illinois) followed by Student-Newman-Keul’s
ost-hoc test was used to analyze group differences in single
oint data. Echocardiographic data were analyzed by analysis
f variance for repeated measures followed by post-hoc analysis
ith Student-Newman-Keul’s test for multiple comparisons.
p value of 0.05 was used to assign significant differences.
esults
total of 76 rats were initially included in this study. Three
ats in the control group and 2 rats in the EMU group died
days after the chest was closed because of a large area of
nfarction. Two rats in the control group and 3 rats in the
MU group died immediately during injection because of
leeding from an injured coronary artery. One rat in the
ontrol group and 1 rat in the EMU group were excluded
ecause no evidence of infarct zone was found. The final 64
ats, namely, 8 rats in each observation period in both
roups, were included for the histological examination and
chocardiography. The mortality was comparable in the 2
roups, and successful EMU injection did not affect mor-
ality during the 42 days of observation. An additional 24
ats were used in the sham group (12 rats) and sham plus
MU group (12 rats).
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March 23, 2010:1250–61 EMU and Cardiac RemodelingMU localization and scar formation on the injection
ite over time of reperfusion. Injection of EMU into the
schemic/reperfused area was visible in the beating heart.
he myocardium that received EMU swelled clearly at the
njection site 3 days after injection (Fig. 1), indicating that
he EMU does not escape into the left ventricular cavity.
fter 7 and 21 days of injection, EMU was still identified
A B
D E
Figure 1 In Situ EMU Injection in Normal and Ischemic/Reperf
(A) Normal heart; (B) normal heart received extracellular matrix emulsion (EMU) in
hearts received EMU injection after 3, 7, 21, and 42 days of reperfusion, respecti
Normal                 3                      
R
Figure 2 Identification of Collagen Deposition and Scar Format
(Top panel) The control group; (bottom panel) the extracellular matrix emulsion (E
stains blue and viable myocardium stains red. There is extensive loss of myocardi
EMU injection reduced deposition of collagen and extension of infarct scar with inceneath the surface of the injection site, but was not clearly
dentified at 42 days. Masson’s trichrome staining revealed
hat the EMU engrafted homogenously within the injured
yocardium, and aligned itself along the host myocardium
ithout distorting ventricular wall geometry, as identified by
emarcation of EMU in the myocardium (Fig. 2). In the
ontrol animals, the collagen deposition was clearly detected
C
F
Hearts
after 42 days of reperfusion; (C, D, E, and F)
he arrows indicate the presence of EMU in the heart.
           21                    42
rfusion (days)
Ischemic/Reperfused Myocardium
roup. The collagen-rich myocardial scar in the anterior wall of the left ventricle
s, with collagen deposition and scar formation at 42 days of reperfusion. The
d mass of viable myocardium within the anterior wall over time of reperfusion.used
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EMU and Cardiac Remodeling March 23, 2010:1250–61tarting from 7 days of reperfusion. At 42 days, the
ollagen-rich myocardial scar extended through the entire
entricular wall and less viable myocardium was detected.
owever, the ischemic/reperfused myocardium appeared more
rganized and circumscribed in the EMU area. The ventricular
all thickness at the site of EMU zone was well preserved. At
2 days of injection, a smaller amount of fibrous tissue was
dentified within the EMU zone, suggesting tissue regenera-
ion. No collagen deposition was detected in the nonischemic
one in both control and EMU groups as well as in the sham
nd sham plus EMU groups (data not shown).
xpression of SCF in myocardium. SCF is expressed in
he larger 45-kDa form and subsequently cleaved to produce
smaller and soluble 31-kDa form when it is activated. SCF
n the 31-kDa form is the ligand for the transmembrane
yrosine kinase receptor proto-oncogene c-kit. As shown in
igure 3, the SCF in 45-kDa form was detected in the
onischemic zone in both control and EMU groups. Three
ays of reperfusion in the control group did not alter SCF
xpression of 45-kDa form, but its level was significantly
ncreased after 7 days. No significant cleavage of the larger
5-kDa form was found relative to the nonischemic zone in
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C
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Figure 3 Expression of SCF in Ischemic/Reperfused Myocardiu
Stem cell factor (SCF) in larger 45-kDa form was detected in the nonischemic zone
injection of EMU (solid bars) significantly increased SCF levels in all forms relative
equal amount of protein loading. Values are mean  SEM (n  8). p  0.05 verhe control animals over the time of reperfusion. However,
MU injection significantly increased SCF expression in
oth 45- and 31-kDa forms during the entire period of
eperfusion compared with the control group. No statisti-
ally significant difference in levels of SCF in larger and
maller forms was detected in the nonischemic zone in both
ontrol and EMU groups as well as in the sham and sham
lus EMU groups (data not shown).
ecruitment of c-kit–positive cells in myocardium. No
-kit–positive cells were detected in the nonischemic myo-
ardium throughout reperfusion in the control and EMU
roups as well as in the sham and sham plus EMU
roups. However, c-kit–positive cells were detected in
he myocardium at 3 days in the control animals, with a
ignificant increase in the number of c-kit–positive cells
t 7 days of reperfusion (Fig. 4). Relative to the control
nimals, the c-kit–positive cells were significantly in-
reased in the EMU injection site, with a peak in
ecruitment of c-kit–positive cells at 7 days. At 21 and 42
ays of reperfusion, c-kit–positive cells in the EMU
roup declined, but were still statistically greater than
hose in the control group.
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March 23, 2010:1250–61 EMU and Cardiac Remodelingccumulation of -SMA– expressing myofibroblasts and
acrophages in myocardium. As shown in Figure 5A,
-SMA–expressing myofibroblasts were detected in the
onischemic myocardium in the control and EMU groups.
elative to the number in the nonischemic myocardium,
-SMA–expressing myofibroblasts were significantly in-
reased after 3 days of reperfusion in the control group, but
educed during subsequent reperfusion periods. However,
MU injection further augmented the number of -SMA–
xpressing myofibroblasts in the myocardium relative to the
ach time point of reperfusion compared with the control
roup, with a peak at 7 days.
Macrophages were detected in the nonischemic myocar-
ium in both the control group and the EMU group, as shown
n Figure 5B. Ischemia/reperfusion caused a significant in-
rease in the macrophage accumulation in myocardium relative
o the nonischemic zone, with a peak at 3 days of reperfusion.
here was a trend toward an increase in macrophage accumu-
ation in the EMU group compared with the control at 3 days,
ut it did not reach a statistical difference. Although the
umber of macrophages accumulated in the myocardium
eclined over the period of reperfusion in both control and
MU groups, EMU injection significantly increased the num-
er of macrophages in the infarcted myocardium during the
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Figure 4 Accumulation of C-Kit–Positive Cells in Ischemic/Rep
(Top panel) C-kit–positive cells were detected in myocardium after 3 days of reper
point in the control group (shaded bars), the number of c-kit–positive cells was sig
tion (solid bars), with a constant increase during 42 days of reperfusion. Values a
versus control. Magnification 200.ourse of the experiment, suggesting that injection of EMU fnhances an infiltration of macrophages during reperfusion.
here was a significant linear relationship in the number of
ccumulated macrophages and -SMA–expressing myofibro-
lasts at 7 days of reperfusion (y  27  0.153*X, r  0.814,
 0.05), suggesting that the migrated macrophages are
otentially involved in recruitment of -SMA–expressing
yofibroblasts during reperfusion.
The -SMA– expressing myofibroblasts and macro-
hages were not detected in myocardium in the sham and
ham plus EMU groups (data not shown). There were only
inor signs of foreign-body reaction with EMU injection as
ematoxylin and eosin staining revealed comparable level in
eutrophil accumulation within the infarcted zone in both
ontrol and EMU groups.
EGF expression and angiogenesis in infarcted myocardium.
he VEGF protein was detected in the sham group and the
ham plus EMU group, but no statistical difference was found
elative to the nonischemic myocardium among these groups
data not shown). Ischemia/reperfusion caused a significant
ncrease in the level of VEGF protein at 3 and 7 days of
eperfusion in the control group. However, its level was
ubsequently reduced at 21 and 42 days (Fig. 6A). Compared
ith the control animals, EMU injection significantly in-
reased level of VEGF protein with a peak at 7 days. Starting
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EMU and Cardiac Remodeling March 23, 2010:1250–61ut were still significantly higher than those in the control
roup. Consistent with these results, VEGF expression was
lso affected by EMU injection, as shown in Figure 6B.
schemia/reperfusion increased intensity of immunohisto-
hemical VEGF staining in the control group at 3 days, but its
xpression was reduced during the following time periods of
eperfusion. However, there was a significant increase in the
xpression of VEGF in the myocardium throughout the entire
eriod of reperfusion in the EMU group.
Enhancement in the level and expression of VEGF by
njecting EMU was accompanied by an increase in newly
ormed microvessels within the EMU zone. As shown in
igure 7, ischemia/reperfusion significantly increased the
ensity of -SMA–positive microvessels during 3 and 7
ays of reperfusion relative to the nonischemic myocardium,
uggesting that the stress initiates a compensating response to
schemia/reperfusion injury. However, the mean density of
-SMA–positive microvessels was subsequently reduced after
1 days in the control animals. The EMU injection signifi-
antly increased the density of -SMA–positive microvessels
n the infarcted zone relative to each time point of reperfusion
n the control group, with a peak increase at 7 days of
eperfusion. A low level in the density of -SMA–positive
icrovessels was detected in myocardium in the sham group
nd sham plus EMU groups, but no significant difference was
ound relative to the density in the nonischemic zones in both
Control
EMU
Control
EMU
Normal              3                   7                 21 
Reperfusion (day
Figure 5 Time Course in Accumulation of Myofibroblast and Ma
Infiltration of myofibroblast (top panel) identified as nonvascular -smooth muscle
panel) are significantly increased at 3 and 7 days of reperfusion in the control gro
bers of these cells during reperfusion relative to each time point observed. Values
EMU (solid bars) versus control (shaded bars). HPF  high-powered field. Magnifiche control group and the EMU group (data not shown). ichocardiographic evaluation of cardiac function and
all thickness. The results from echocardiographic eval-
ation are summarized in Table 1. No significant statis-
ical difference was found in all echocardiographic pa-
ameters measured in the sham and sham plus EMU
roups, so data from these 2 groups were averaged.
uring 42 days of reperfusion in the control group,
VSD, LVDD, EDV, and ESV were significantly higher
ompared with the baseline values. In addition, the stroke
olume was significantly lower and indexes of systolic
unction, namely, fraction shortening and EF were sig-
ificantly reduced, suggesting contractile dysfunction
Fig. 8). An example of pulsed-wave Doppler recordings
f mitral inflow is shown in Figure 9A. Ischemia/
eperfusion increased both early diastolic filling (E-wave)
elocity and atrial filling (A-wave) velocity, and therefore
esulted in a significant decrease in the ratio of E-wave to
-wave velocity (E/A) relative to baseline values in the
ontrol animals. The EMU injection significantly im-
roved changes in systolic and diastolic functions mea-
ured in all time points relative to those in the control
roup (Table 1, Figs. 8 and 9A). However, the improve-
ents in systolic and diastolic functions secondary to
MU injection partially declined relative to the baseline
alues during the periods of 42 days of reperfusion,
uggesting lack of full protection by a single EMU
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March 23, 2010:1250–61 EMU and Cardiac RemodelingThe wall thickness of the infarcted middle anterior and poste-
ior septum was measured from echocardiographic images. As
hown in Figure 9B, ischemia/reperfusion caused significant wall
hinning at 42 days, but this change was preserved with EMU
njection. The wall thickness of infarcted middle anterior
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nfarcted middle anterior septum that did not receive EMU
njection, as indicated by an arrowhead in Figure 9B.
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fter myocardial infarction, ECM turnover is one of the
ost important factors in retaining tissue integrity and
reventing maladaptive remodeling. A normal ECM pro-
ides the appropriate cellular microenvironment for cell
igration, growth, and differentiation, and also serves as a
torage depot for growth factors, hormones, and cytokines
esponsible for cellular signaling functions (1,2). This study
evealed that the injection of EMU into the infarcted
chocardiographic DataTable 1 Echocardiographic Data
Index
Control Group
Base 3 7 21
LVSD, mm 2.0 0.8 1.9 0.6 1.3 0.4* 1.3 0.4* 1.3
LVSS, mm 2.6 0.3 1.4 0.1* 1.4 0.5* 1.3 0.1* 1.4
LVDD, mm 6.9 0.6 6.7 1.2 7.4 1.1 8.3 0.9* 9.3
LVDS, mm 4.3 0.5 5.6 0.1 5.4 0.3 6.4 1.1* 7.0
EDV, ml 0.8 0.2 0.6 0.4 1.1 0.4 1.3 0.4* 1.6
ESV, ml 0.2 0.1 0.3 0.1 0.5 0.2 0.6 0.3* 1.0
LVPWD, mm 1.9 0.3 1.7 0.1 2.0 0.2 2.1 0.4 2.1
LVPWS, mm 2.4 0.3 2.0 0.2 2.1 0.1 2.4 0.2 2.1
Ant-sep, mm 2.0 0.1 1.6 0.2* 1.6 0.5* 1.4 0.2* 1.3
Post-sep, mm 2.1 0.1 2.0 0.2 2.1 0.1 2.0 0.1 2.1
alues are mean  SEM. *p  0.05 versus baseline values; †p  0.05 versus control group.
Ant-sep  middle anterior septum; EDV  end-diastolic volume; ESV  end-systolic volume;
entricular posterior wall diastol; LVPWS  left ventricular posterior wall systole; Post-sep  midd
Base Control
Reperf
FS
*    *    *    *   *  
† † †
†
†
(%)  (%)
B
Base 3 7 21 42 
0
10
20
30
40
50
Base 3
20
30
40
50
60
70
80
Figure 8 Cardiac Systolic Function During the Course of the Ex
Cardiac function was detected by echocardiography using a 2-dimensional guided
emulsion (EMU) group (open circles), and sham group (solid triangles). Ischemia
fraction shortening (FS), ejection fraction (EF), and stroke volume (SV). Relative to
systolic function during reperfusion. No changes in cardiac systolic and diastolic fu
versus respective baseline values in the control group and EMU group; †p  0.05yocardium significantly increases expression of stem cell
actor and recruits bone marrow–derived c-kit–positive
ells. Consistent with enhanced angiogenesis, EMU injec-
ion promoted -SMA–expressing myofibroblast infiltra-
ion and macrophage accumulation. Accordingly, EMU
njection increased ventricular wall thickness and the im-
roved cardiac functions. These data suggest that the
avorable effects of this xenogeneic EMU on cardiac remod-
ling may relate to an improvement of microenvironment
uring tissue repair after infarction.
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March 23, 2010:1250–61 EMU and Cardiac RemodelingStem cell factor is a pleiotropic cytokine that has 2
lternatively spliced forms: the membrane-bound larger
5-kDa form and the smaller soluble 31-kDa form. The
arger SCF form is primarily expressed in fibroblasts and can
e cleaved to produce soluble 31-kDa form by multiple
actors, such as granulocyte colony-stimulating factor, stro-
al cell-derived factor-1, or VEGF (18). With respect to a
ole of SCF in cardiac remodeling, it has been reported that
CF enhances endogenous cardiac repair working through
ecruitment of the bone marrow–derived c-kit progenitor
ells and other differentiated precursor cells (18,19). Recent
tudies have provided direct evidence showing that SCF
ritically affects cardiac healing after myocardial infarction
y modulating differentiation of myofibroblasts from c-kit
ells and stimulating angiogenesis through VEGF released
rom myofibroblasts (19). In the current study, we found
hat the soluble SCF level in the control group was
ignificantly detected only at 7 days of reperfusion, which
orresponded to a significant accumulation of c-kit–positive
ells, and then returned back to the baseline level at 21 and
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a b
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Figure 9 Cardiac Diastolic Function and Ventricular Wall Thick
Cardiac diastolic function (A) measured by a ratio of E-wave to A-wave velocity (E/
trol group (solid squares), but significantly preserved by extracellular matrix emuls
mean  SEM (n  8). p  0.05 versus baseline values in the control and EMU g
(mid) anterior (ant) and posterior septum (sep) was measured by echocardiograph
EMU group (d), respectively. Relative to the control group, EMU injection increased
cover the entire anterior wall of the left ventricle on the same heart (arrowhead).2 days (18,20). However, EMU injection augmented SCF sevels at 3 days of reperfusion, and its increased level was
onstantly maintained throughout 42 days. These data were
onsistent with the time course in increased number of
-kit–positive cells in the EMU region, suggesting a role of
CF/c-kit system in EMU-modulated cardiac repair. Since
-kit–positive cells were also detected in the infarcted
yocardium of the control group, we cannot exclude the
ossibility that resident c-kit–positive cells were accumu-
ated in the myocardium after infarction. However, a sig-
ificant increase in the number of c-kit–positive cells with
MU injection suggests that these cells are largely derived
rom the bone marrow (18).
Myofibroblast, a specialized phenotype of cell derived
rom fibroblast that expresses -SMA, has been described
s a contractile cell for granulation repair tissue. In response
o myocardial infarction, accumulation of myofibroblasts in
he infarcted myocardium may contribute to scar tissue
tabilization by indirectly regulating secretion of angiogenic
actors for blood vessel construction and directly depositing
ollagen for scar tissue formation (21–26). In the current
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EMU and Cardiac Remodeling March 23, 2010:1250–61yofibroblasts was detected after 3 days post-infarction, the
ccumulation of myofibroblasts declined between 7 and 42
ays in the control animals, which is a period responsible for
aintaining structural integrity and wound closure of heal-
ng scars (21,22). The origin of indigenous myocardial
yofibroblasts is unresolved, but recent studies have dem-
nstrated that formation of myofibroblast-rich repair tissue
as significantly inhibited when the bone marrow–derived
-kit cells are mutated. In these studies, replacement of the
utant bone marrow with c-kit cells isolated from the
ild-type animals rescued the myofibroblast proliferation,
uggesting a role of c-kit cells in transdifferentiation of
yofibroblast phenotype (18). The current study raises the
ossibility that injection of EMU preserves natural sources
f ECM, protects native ECM from degradation, and there-
ore provides a cellular microenvironment for c-kit cell migra-
ion and differentiation. Compared with the control animals,
he number of infiltrated -SMA–expressing myofibroblasts
n EMU region was significantly increased at 7 and 21 days
fter reperfusion, consistent with an increase in accumulation
f c-kit–positive cells during these time periods. These data
uggest that mobilization of c-kit–positive cells from the
one marrow facilitated by EMU may increase the myofi-
roblast differentiation, enhance angiogenesis, and thereby
rive efficient endogenous cardiac repair. In this regard, the
obilization of the bone marrow–derived cells to the small
ntestinal submucosa has been previously demonstrated to
articipate in the tissue remodeling process in other appli-
ations (27).
Infiltrating macrophages into the damaged tissue has
een associated with myofibroblast accumulation and an-
iogenesis. A recent study has reported that macrophage
epletion with intravenous injection of clodronate-
ontaining liposomes reduces infiltration of myofibroblasts
nd intensity of neovascularization after myocardial injury.
long with these changes, the wound healing was impaired
nd the mortality was increased (28). In addition, direct
njection of human macrophages into the infarcted myocar-
ium in rat promoted vascularization, enhanced myofibroblast
ccumulation, and improved cardiac function (29). In the
urrent study, we found that injection of EMU significantly
ncreased macrophage accumulation when compared with the
ontrol animals during 42 days of reperfusion, suggesting a role
or macrophage accumulation in cardiac repair. A linear rela-
ionship between macrophages and -SMA–positive cells
ccumulated at 7 days of reperfusion may indicate that migra-
ion of macrophages is potentially responsible for myofibro-
last accumulation after EMU injection.
Formation of microvessels in the infarcted myocardium is
rucial during the healing process. Although the mecha-
isms responsible for the neovascularization after myocar-
ial infarction have not been fully elucidated, an increase in
opulations of -SMA– expressing myofibroblasts and
acrophages in the infarcted myocardium has been associ- mted with enhanced angiogenesis after myocardial infarction
21,28). Myofibroblasts and macrophages secrete large
mount of VEGF, a critical angiogenic factor for inducing
eovascularization in granulation repair tissue, when these
ells are activated after myocardial infarction (21,28). In the
urrent study, we demonstrated the dynamic alterations in
EGF expression and microvessel density during matura-
ion of the healing myocardial scar, and assumed that these
hanges modulated by EMU are associated with increased
ccumulation of -SMA–expressing myofibroblasts and
acrophages. These data signified an important relation-
hip among neovascularization, myofibroblasts and macro-
hages in EMU-enhanced cardiac angiogenesis.
Intramyocardial injection of several biomaterials into the
eart have shown the beneficial effects on tissue remodeling
fter myocardial infarction, most likely due to the mechan-
cal support and the wall tension reduction (5,9,12). In the
urrent study, we found that EMU injection significantly
mproves cardiac systolic and diastolic function for as long as
2 days of reperfusion when compared with the saline
ontrol group. These data were consistent with a significant
ncrease in the number of c-kit–positive cells, accumulation
f -SMA–expressing myofibroblasts and macrophages, as
ell as higher levels of newly constructed blood vessels. In
ddition to these biological effects, the EMU may also
revent maladaptive cardiac remodeling by providing struc-
ural support to the ventricular wall where they form
-dimensional matrices upon injection, conform to the geom-
try of the ventricular space, and increase ventricular wall
hickness. Therefore, the capability of EMU to deform with
ynamically improved myocardial microenvironment and to
lign with the injured myocardium may provide better incor-
oration in cell recruitment and cardiac recovery.
This is not a study to show the “cause-effect” relation-
hips among cell migration, cell proliferation, and tissue
ngiogenesis during cardiac healing with EMU injection.
e selected recruitment of several different cell types,
xpression of VEGF, and formation of blood vessels as
arkers, which have been previously demonstrated to be
eneficial in tissue regeneration (11,12), to show protective
ffects of EMU injection after myocardial infarction. How-
ver, there is a limitation in this rat model of ischemia and
eperfusion with EMU injection. The thickness of ventric-
lar anterior wall in rat is2 mm; it is very difficult to apply
or multiple injections to fully cover the entire area at risk
yocardium in the same heart. Because we still see the
ecline in cardiac function over time of reperfusion (Figs.
and 9), future work in a larger animal model is
arranted to demonstrate whether multiple EMU injec-
ions to a single heart could provide the maximal protec-
ion. In addition, more work is needed to determine what
he optimal elements of EMU in modulating remodeling
re, and how EMU protects the heart through cell
igration and differentiation.
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March 23, 2010:1250–61 EMU and Cardiac Remodelingonclusions
his is the first histological and functional study to dem-
nstrate the beneficial effects of EMU injection on mal-
daptive cardiac remodeling. Relative to other materials
njected into the heart after myocardial infarction (5,9–11),
e assume that this natural EMU is able to provide the host
proper matrix microenvironment for cell survival and
etention in the myocardium by its complex structures,
hich may be favorable not only in providing mechanical
upport but also in improving cardiac function. These data
rovide direct experimental evidence to show whether
dverse cardiac remodeling could be modified by supplying
CM after myocardial infarction.
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